These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 1357158

  • 1. Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist.
    Callaway CW, Geyer MA.
    J Pharmacol Exp Ther; 1992 Oct; 263(1):318-26. PubMed ID: 1357158
    [Abstract] [Full Text] [Related]

  • 2. Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
    Rempel NL, Callaway CW, Geyer MA.
    Neuropsychopharmacology; 1993 May; 8(3):201-11. PubMed ID: 8099482
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors.
    McCreary AC, Bankson MG, Cunningham KA.
    J Pharmacol Exp Ther; 1999 Sep; 290(3):965-73. PubMed ID: 10454466
    [Abstract] [Full Text] [Related]

  • 4. Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine.
    Callaway CW, Rempel N, Peng RY, Geyer MA.
    Neuropsychopharmacology; 1992 Sep; 7(2):113-27. PubMed ID: 1358088
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
    Callaway CW, Wing LL, Geyer MA.
    J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
    [Abstract] [Full Text] [Related]

  • 10. Diminished corticotropin and enhanced prolactin responses to 8-hydroxy-2(di-n-propylamino)tetralin in methylenedioxymethamphetamine pretreated rats.
    Poland RE.
    Neuropharmacology; 1990 Nov; 29(11):1099-101. PubMed ID: 1982341
    [Abstract] [Full Text] [Related]

  • 11. Chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA].
    Ross JD, Herin DV, Frankel PS, Thomas ML, Cunningham KA.
    Drug Alcohol Depend; 2006 Feb 01; 81(2):117-27. PubMed ID: 16054778
    [Abstract] [Full Text] [Related]

  • 12. Tolerance to 3,4-methylenedioxymethamphetamine is associated with impaired serotonin release.
    Jones K, Brennan KA, Colussi-Mas J, Schenk S.
    Addict Biol; 2010 Jul 01; 15(3):289-98. PubMed ID: 20477756
    [Abstract] [Full Text] [Related]

  • 13. Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade.
    Ramos M, Goñi-Allo B, Aguirre N.
    Neuropsychopharmacology; 2005 Dec 01; 30(12):2180-91. PubMed ID: 15841107
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.